Literature DB >> 29545715

Cancer incidence in Beijing, 2014.

Shuo Liu1, Lei Yang1, Yannan Yuan1, Huichao Li1, Jing Tian1, Sijia Lu1, Ning Wang1, Jiafu Ji1,2.   

Abstract

OBJECTIVE: To analyze cancer incidence data in Beijing in 2014 and temporal trends for selected common cancers during 2005 and 2014.
METHODS: A total of 144 secondary and tertiary hospitals reported newly diagnosed cancer cases to Beijing Cancer Registry, which covers 13 million residents in Beijing. The cancer incidence rate was calculated in strata by cancer type, sex, age group and area. The population composition of China in 1982 and Segi's population structure were used to calculate age-standardized rates. Extensive procedures were used to assure the quality of the data.
RESULTS: The overall data quality indicators of the percentage of morphology verification (MV) (%), the percentage of death certificate-only (DCO) (%) and the mortality to incidence ratio (M/I) were 72.15%, 0.94% and 0.54 respectively. A total of 45,300 new cancer cases were diagnosed in Beijing in 2014. The incidence rate was 341.92/100,000 (343.50/100,000 in males, 340.33/100,000 in females), and the age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 143.48/100,000 and 182.99/100,000, respectively. The cumulative incidence rate for cancer before 75 years was 20.61%. Cancers of lung, colorectum, liver, stomach and prostate were the top five common cancer types for males, while cancers of breast, lung, thyroid, colorectum and uterus were the top five common cancer types for females. The different patterns were also observed between rural and urban areas. Regarding temporal trends, the incidence of thyroid cancer has the fastest growth between 2005 and 2014. The incidence of liver cancer decreased, and stomach and esophageal cancer also decreased significantly for males in the last decade. Incidence rate for lung cancer was relatively stable during that period of time.
CONCLUSIONS: With more than 45,000 new cases in Beijing in 2014, cancer remains an important public health problem. Actions should be taken to diminish total cancer incidence in Beijing.

Entities:  

Keywords:  Beijing; Cancer; epidemiology; incidence

Year:  2018        PMID: 29545715      PMCID: PMC5842227          DOI: 10.21147/j.issn.1000-9604.2018.01.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  11 in total

1.  [Study on the rates of smoking among the residents of Beijing, from 1997 to 2004].

Authors:  Chun-yu Li; Xiao-bo Cui; Ying-sheng Rao; Xin-gui Sun
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2007-05

2.  [Time trends of the incidence of thyroid cancer in urban Guangzhou, 2000-2011].

Authors:  Ke Li; Guozhen Lin; Qin Zhou; Xianbo Wu
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2015-02

3.  [Trend in incidence of thyroid cancer in Jiading district of Shanghai, 2003-2013].

Authors:  F Xiang; F Huang; Y Y Zhang; Y Q Shao; N Wang; Q W Jiang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2016-07-06

4.  [Epidemiology and management guidelines of thyroid cancer].

Authors:  S T Liu; X Zhang
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2016-02

5.  Cancer incidence and mortality in China, 2013.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Changfa Xia; Tingting Zuo; Zhixun Yang; Xiaonong Zou; Jie He
Journal:  Cancer Lett       Date:  2017-05-03       Impact factor: 8.679

Review 6.  Preventable exposures associated with human cancers.

Authors:  Vincent James Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Lauby-Secretan; Fatiha El Ghissassi; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Christopher P Wild
Journal:  J Natl Cancer Inst       Date:  2011-12-12       Impact factor: 13.506

7.  Current Cigarette Smoking Among Adults - United States, 2005-2015.

Authors:  Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

8.  [A sero-epidemiological study of hepatitis B among general population in Beijing].

Authors:  P Gao; H Wang; W X Chen; Y N Sun; W Zhang; X H Pang; X He; J Wu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2016-05

9.  [Morbidity and mortality of malignant tumor in Zhejiang province, 2014].

Authors:  F R Fei; R Y Hu; J M Zhong; W W Gong; Q F He; H Wang; J Pan; H B Wu; M Wang; M Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2016-05

10.  Cancer incidence and mortality in China in 2013: an analysis based on urbanization level.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Tingting Zuo; Changfa Xia; Zhixun Yang; Jie He
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

View more
  10 in total

1.  The Incidence of Lymphoma in Beijing: Comparing Results from MIS-CASS (2019) and Beijing Cancer Registry (2017).

Authors:  Hongrui Tian; Weiping Liu; Yuqin Song; Lan Mi; Zhen Liu; Mengfei Liu; Chuanhai Guo; Fangfang Liu; Ying Liu; Yaqi Pan; Jun Zhu; Zhonghu He; Yang Ke
Journal:  China CDC Wkly       Date:  2021-12-24

2.  Trends of Esophageal Cancer Incidence and Mortality and Its Influencing Factors in China.

Authors:  Bang Li; Yan Liu; Jiao Peng; Chao Sun; Weiqing Rang
Journal:  Risk Manag Healthc Policy       Date:  2021-11-30

3.  Risk of secondary rectal cancer and colon cancer after radiotherapy for prostate cancer: a meta-analysis.

Authors:  Zhiguo Zhu; Shankun Zhao; Yangzhou Liu; Jiamin Wang; Lianmin Luo; Ermao Li; Chaofeng Zhang; Jintai Luo; Zhigang Zhao
Journal:  Int J Colorectal Dis       Date:  2018-07-02       Impact factor: 2.571

4.  Secular trends in incidence of lung cancer by histological type in Beijing, China, 2000-2016.

Authors:  Lei Yang; Ning Wang; Yannan Yuan; Shuo Liu; Huichao Li; Jing Tian; Jiafu Ji; Aiguo Ren
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

5.  Trends in incidence and mortality of female breast cancer during transition in Central China.

Authors:  Yao Cheng; Yaqiong Yan; Jie Gong; Niannian Yang; Shaofa Nie
Journal:  Cancer Manag Res       Date:  2018-11-23       Impact factor: 3.989

6.  Incidence and mortality of thyroid cancer in China, 2008-2012.

Authors:  Lingbin Du; Runhua Li; Minghua Ge; Youqing Wang; Huizhang Li; Wanqing Chen; Jie He
Journal:  Chin J Cancer Res       Date:  2019-02       Impact factor: 5.087

7.  Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study.

Authors:  Xi Zhang; Lei Yang; Shuo Liu; Huichao Li; Qingyu Li; Yangyang Cheng; Ning Wang; Jiafu Ji
Journal:  Front Oncol       Date:  2021-11-04       Impact factor: 6.244

8.  Esophageal Carcinoma and Associated Risk Factors: A Case-control Study in Two Tertiary Care Hospitals of Kabul, Afghanistan.

Authors:  Ramin Saadaat; Jamshid Abdul-Ghafar; Ahmed Maseh Haidary; Nooria Atta; Tazeen Saeed Ali
Journal:  Cancer Manag Res       Date:  2022-08-10       Impact factor: 3.602

9.  Prognostic comparison between radical prostatectomy and radiotherapy in prostate cancer patients at different stages and ages.

Authors:  Fei Wang; Yuanming Fan; Xiaojian Yin; Lian-Wen Qi; Gaoxiang Ma; Qinbo Yuan
Journal:  Aging (Albany NY)       Date:  2021-06-29       Impact factor: 5.682

10.  An innovative anti-cancer Chinese herbal formula exhibited multi-targeted efficacies in metastatic breast cancer mouse model.

Authors:  Grace Gar-Lee Yue; Julia Kin-Ming Lee; Ben Chung-Lap Chan; Hin-Fai Kwok; Sandy Wan-Heng Hoi; Daniel Man-Yuen Sze; Kwok-Pui Fung; Ping-Chung Leung; Clara Bik-San Lau
Journal:  Chin Med       Date:  2018-12-22       Impact factor: 5.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.